NCT06838793
ITPB 1 vs 3 in VATS
At risk: Primary completion moved 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Mar 1, 2026 to Mar 1, 2027 Show 4 more changesShow less
- Start date: Mar 4, 2025 to Mar 4, 2026
- Eligibility criteria expanded, about 7 words
- Study completion pushed from Apr 30, 2026 to Apr 30, 2027
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Mar 1, 2025 to Mar 4, 2025
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (4)
Arms and interventions
Patients with primary carcinoma lung scheduled for resection under VATS procedure and randomized in SL group will receive a single level ITPB at retro SCTL space injection and it will be performed at T5 vertebral level after which two subsequent IM sham injections with 2-3 ml 0.9% saline will be performed at T3 and T7 level.
Patients with primary carcinoma lung scheduled for resection under VATS procedure and randomized in TL group will receive injection at T3, T5 and T7.
Procedures: Single Level Intertransverse Process Block, Three Level Intertransverse Process Block
Sites
1 site in 1 country
- Department of Anaesthesia, Pain and Perioperative Medicine, Prince of Wales Hospital, ShatinHong Kong, Hong Kong